GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncoclinicas do Brasil Servicos Medicos ONCO3.SA · BRL

Health Care · B3 · 🇧🇷 Brazil

Compare

1.04

+6.12%

Close of 9 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Oncoclinicas do Brasil Servicos Medicos

Its shares trade on B3 under the ticker ONCO3.SA. It has been listed since 10 August 2021. In the fiscal year to 31 December 2025, it reported revenue of BRL 5.74bn and a net loss of BRL 3.62bn. At that date it held total assets of BRL 7.13bn and shareholders' equity of BRL 900.9m.

Oncoclínicas do Brasil Serviços Médicos SA operates as a holding company, which engages in oncology clinics through the health care segment. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2021-08-10. The firm provides of medical services focused on Oncology. The Company, since its foundation, in addition to acting directly in the treatment of cancer patients, has dedicated itself to the study and identification of the appropriate therapy opportunities for patients and the growth trends in the sector. The firm holds interest in a number of subsidiaries, such as Centro de Quimioterapia Antiblastica e Imunoterapia SA, Centro Mineiro de Infusoes SA, and Centro Paulista de Oncologia SA.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
10 Aug 2021

Leadership

Pay as last reported

  • Eduardo AlvesDirector
  • Cinthia AmbrogiDirector
  • Giovane CostaDirector
  • Marcos CunhaDirector
  • Ricardo da Silva SantoroDirector
  • Andre FariaDirector
  • Bruno FerrariDirector
  • Mr. Cristiano Affonso Ferreira De CamargoDirector
  • Mr. Rodrigo Ferreira Medeiros Da SilvaDirector
  • Guilherme FerriDirector
  • Carlos Gil Moreira FerreiraDirector
  • Marcia Maria Oliveira MenezesDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Operates as a holding company in oncology clinics within the health care sector.
  • Headquartered in Sao Paulo, Brazil, with a focus on oncology medical services.
  • Provides medical services focused on cancer treatment and therapy identification.

Weaknesses

  • No specific weaknesses mentioned in the provided information.
  • No details on financial performance or market position provided.
  • No information on competitive advantages or operational challenges.

Opportunities

  • Growth trends in the oncology sector present potential for expansion.
  • Expansion through subsidiaries like Centro de Quimioterapia Antiblastica e Imunoterapia SA.
  • Focus on study and identification of appropriate therapy opportunities for patients.

Threats

  • No specific threats mentioned in the provided information.
  • No details on market competition or regulatory challenges provided.
  • No information on potential risks to the business model.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.